About: http://hub.abes.fr/bmj/periodical/ard/2012/volume_71/issue_3/w

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : http://hub.abes.fr/bmj/periodical/ard/2012/volume_71/issue_3/w Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/bmj/periodical/ard/2012/volume_71
has manifestation of work	http://hub.abes.fr/bmj/periodical/ard/2012/volume_71/issue_3/m/print http://hub.abes.fr/bmj/periodical/ard/2012/volume_71/issue_3/m/web
Date Copyrighted	2012
Rights	Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
issue	3
Access Rights	open-access
is Is Part Of of	Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations Immediate access rheumatology clinic: efficiency and outcomes Detection of periarticular urate deposits with dual energy CT in patients with acute gouty arthritis Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0 Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets The sympathetic nervous system stimulates anti-inflammatory B cells in collagen-type II-induced arthritis Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr−/− mice Inflammation and ankylosis: still an enigmatic relationship in spondyloarthritis A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis Reversible male infertility under treatment with an anti-TNFα agent: a case report MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis IgG4 immune response in Churg-Strauss syndrome Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases Comparison of features by MRI and radiographs of the interphalangeal finger joints in patients with hand osteoarthritis Early menopause is an independent predictor of rheumatoid arthritis Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration Biological treatment of rheumatoid arthritis: towards a more cost-effective re-treatment regimen using rituximab?

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata